View Older Stories View More Recent Stories
-
Ionis Pharmaceuticals (IONS) PT Lowered to $74 at BMO Capital
-
Financial 15 Split Corp. Completes Exchange Offer
-
Form 13F-NT BMO CAPITAL MARKETS CORP For: Mar 31
-
UPDATE: BMO Capital Downgrades Texas Roadhouse (TXRH) to Market Perform
-
Mitel Networks (MITL) to be Acquired by Affiliates of Searchlight Capital Partners for $2.0 Billion
-
Mitel Enters into Definitive Arrangement Agreement to be Acquired by Affiliates of Searchlight Capital Partners for $2.0 Billion
-
Mitel Enters into Definitive Arrangement Agreement to be Acquired by Affiliates of Searchlight Capital Partners for $2.0 Billion
-
TCF Financial (TCF) PT Raised to $28 at BMO Capital
-
Zions Bancorp (ZION) PT Lowered to $57 at BMO Capital
-
Hasbro (HAS) PT Lowered to $80 at BMO Capital
-
Sun Communities, Inc. Reports 2018 First Quarter Results
-
ELS Reports First Quarter Results
-
GrafTech Announces the Closing of its Initial Public Offering
-
INGREDION TO PRESENT AT BMO CAPITAL MARKETS 13TH ANNUAL FARM TO MARKET CONFERENCE IN NEW YORK
-
BMO Capital on SAGE Therapeutics (SAGE): 'Another Important Milestone Achieved with Brexanolone Filing for PPD'
-
BMO Capital Downgrades Restaurant Brands International (QSR) to Market Perform
-
BMO Capital Upgrades Kansas City Southern (KSU) to Outperform
-
GFL Environmental Inc. announces $5.125 Billion recapitalization with new investors led by BC Partners and their partner OTPP
-
Financial 15 Split Corp. Exchange Offer Results
-
Ionis Pharmaceuticals (IONS) PT Raised to $75 at BMO Capital on Expanded Biogen Deal
-
Trilogy Metals Closes $28.7 Million Bought Deal Financing
-
FMC Corporation's Pierre Brondeau and Mark Douglas to Speak at the BMO Capital Markets 13th Annual Farm to Market Conference
-
UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen
-
Rigel Pharma (RIGL) Prices 16M Share Common Offering at $3.90/Sh
-
BMO Capital Upgrades The Macerich Company (MAC) to Outperform
-
KeyCorp (KEY) PT Lowered to $24 at BMO Capital
-
Signature Bank (SBNY) PT Lowered to $171 at BMO Capital
-
BB&T Capital (BBT) PT Lowered to $63 at BMO Capital
-
Rigel Announces Pricing Of Public Offering Of Common Stock
-
Clarification and Retraction, Hiku Brands and WeedMD to Merge in Transformational Transaction to Create Vertically Integrated Cannabis Company
-
GrafTech (EAF) IPO Opens Modestly Lower
-
Bari Adcom Negative for Eli Lilly (LLY) and AbbVie (ABBV), Positive for Pfizer (PFE) - BMO
-
GrafTech International Ltd. (EAF) Prices 35M Share IPO at $15/Sh
-
Aeglea BioTherapeutics (AGLE) Prices 4.5M Share Common Offering at $8/Sh
-
Cathay General Bancorp (CATY) PT Lowered to $48 at BMO Capital
-
Alcoa (AA) PT Raised to $80 at BMO Capital
-
GrafTech Announces the Pricing of Its Initial Public Offering
-
Aeglea BioTherapeutics Prices Public Offering of Common Stock
-
Aeglea BioTherapeutics Prices Public Offering of Common Stock
-
Rigel Pharma (RIGL) Announces Proposed 15M Share Common Offering
-
Rigel Announces Proposed Public Offering Of Common Stock
-
Comerica (CMA) PT Lowered to $109 at BMO Capital; 'Weaker PPNR Partly Offset by Lower LLP'
-
CSX (CSX) PT Raised to $65 at BMO Capital
-
Celanese (CE) PT Raised to $137 at BMO Capital
-
Rigel Pharmaceuticals (RIGL) PT Raised to $8 at BMO Capital on FDA Approval
-
Aeglea BioTherapeutics (AGLE) Announces 4.5M Share Common Offering
-
Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock
-
Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock
-
Goldman Sachs (GS) PT Raised to $245 at BMO Capital, 'Happy Days Are here Again'
-
Bristol-Myers Squibb Co. (BMY) PT Lowered to $47 at BMO Capital; 'More Headwinds and Uncertainty Ahead'

